These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 15363722

  • 1. Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of the American Society for Reproductive Medicine.
    Fertil Steril; 2004 Sep; 82 Suppl 1():S181-3. PubMed ID: 15363722
    [No Abstract] [Full Text] [Related]

  • 2. Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of the American Society for Reproductive Medicine.
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S221-3. PubMed ID: 17055827
    [No Abstract] [Full Text] [Related]

  • 3. Insulin-sensitizing agents in women with polycystic ovary syndrome.
    Pasquali R, Gambineri A.
    Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
    [Abstract] [Full Text] [Related]

  • 4. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of American Society for Reproductive Medicine.
    Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
    [Abstract] [Full Text] [Related]

  • 5. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients.
    Palomba S, Falbo A, Orio F, Zullo F.
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):364-73. PubMed ID: 18660688
    [Abstract] [Full Text] [Related]

  • 6. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA, Hernández Marín I, Ayala AR.
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [Abstract] [Full Text] [Related]

  • 7. Clinical inquiries. Do insulin-sensitizing drugs increase ovulation rates for women with PCOS?
    Andy C, Flake D, French L.
    J Fam Pract; 2005 Feb; 54(2):156, 159-60. PubMed ID: 15689292
    [No Abstract] [Full Text] [Related]

  • 8. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.
    Checa MA, Requena A, Salvador C, Tur R, Callejo J, Espinós JJ, Fábregues F, Herrero J, Reproductive Endocrinology Interest Group of the Spanish Society of Fertility.
    Hum Reprod Update; 2005 Feb; 11(4):375-90. PubMed ID: 15878899
    [Abstract] [Full Text] [Related]

  • 9. Insulin-sensitizing drugs for polycystic ovary syndrome.
    Med Lett Drugs Ther; 2003 Apr 28; 45(1155):35-6. PubMed ID: 12719696
    [No Abstract] [Full Text] [Related]

  • 10. Effectiveness of insulin sensitizing drugs for polycystic ovary syndrome.
    Julson H.
    Am Fam Physician; 2007 Nov 01; 76(9):1308-9. PubMed ID: 18019873
    [No Abstract] [Full Text] [Related]

  • 11. Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
    Glintborg D, Andersen M, Richelsen B, Bruun JM.
    Clin Endocrinol (Oxf); 2009 Nov 01; 71(5):652-8. PubMed ID: 19170716
    [Abstract] [Full Text] [Related]

  • 12. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C, Cardoza L, Coutiño B, Hidalgo R, Arteaga-Troncoso G, Parra A.
    J Endocrinol; 2005 Jan 01; 184(1):233-9. PubMed ID: 15642799
    [Abstract] [Full Text] [Related]

  • 13. Drug treatments for polycystic ovary syndrome.
    Radosh L.
    Am Fam Physician; 2009 Apr 15; 79(8):671-6. PubMed ID: 19405411
    [Abstract] [Full Text] [Related]

  • 14. Polycystic ovary syndrome and insulin resistance.
    Plosker SM.
    Med Health R I; 2003 Jan 15; 86(1):12-5. PubMed ID: 12633015
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS.
    Chang Gung Med J; 2006 Jan 15; 29(5):445-7. PubMed ID: 17214387
    [Abstract] [Full Text] [Related]

  • 17. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.
    Hum Reprod; 2005 Dec 15; 20(12):3333-40. PubMed ID: 16123091
    [Abstract] [Full Text] [Related]

  • 18. [Metformin for the treatment of polycystic ovary syndrome].
    Pekhlivanov B, Mitkov M.
    Akush Ginekol (Sofiia); 2005 Dec 15; 44(4):37-41. PubMed ID: 16028378
    [No Abstract] [Full Text] [Related]

  • 19. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
    Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM.
    Hum Reprod; 2006 Jan 15; 21(1):109-20. PubMed ID: 16155076
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.